Package 55150-337-02

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ed526447-a4fe-403b-8f08-21ce1b2fa8b7", "openfda": {"nui": ["N0000175604", "N0000175075"], "upc": ["0355150337026"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["ed526447-a4fe-403b-8f08-21ce1b2fa8b7"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-337-02", "marketing_start_date": "20220502"}], "brand_name": "BORTEZOMIB", "product_id": "55150-337_ed526447-a4fe-403b-8f08-21ce1b2fa8b7", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "55150-337", "generic_name": "BORTEZOMIB", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BORTEZOMIB", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA212825", "marketing_category": "ANDA", "marketing_start_date": "20220502", "listing_expiration_date": "20261231"}